Vildagliptin & Metformin Hydrochloride Tablets – Effective dual-action control for Type 2 Diabetes with cardiovascular benefits..
ITVIL M 50/500: The Composition of Vildagliptin 50 mg + Metformin 500 mg combines Vildagliptin, a DPP-4 inhibitor, and Metformin, a biguanide, to provide effective and targeted control of blood sugar levels in Type 2 diabetes. Vildagliptin increases incretin levels, reduces glucagon secretion, delays gastric emptying, and enhances insulin production, while Metformin improves insulin sensitivity, inhibits hepatic glucose production, and promotes peripheral glucose uptake. This combination offers comprehensive management of diabetes with added benefits for cardiovascular health.
Recommended by Specialists:
✅Endocrinologists: It is preferred to treat the disease associated with long-term management of Type 2 Diabetes Mellitus.
✅General Physicians: It is preferred to treat the disease associated with routine blood sugar control
Key benefits of Vildagliptin & Metformin Hydrochloride Tablets – ITVIL M 50/500:
✅Synergistic Glycemic Control: This combination of Vildagliptin’s incretin-enhancing action and Metformin’s reduction of hepatic glucose production effectively manages fasting and postprandial blood glucose levels.
✅Cardioprotective Benefits: Vildagliptin is particularly suitable for diabetic patients with cardiovascular risks, improving beta-cell function and reducing pancreatic stress over long-term use.
✅ Patient Safety and Tolerability: There is a low risk of hypoglycemia and gastrointestinal side effects, making it suitable even in patients with mild to moderate renal impairment.
Indications:
✅Type 2 Diabetes Mellitus
✅Type 2 Diabetes with cardiovascular disease
✅Inadequate glycemic control with monotherapy